Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Neurotech International Ltd

NTI
Current price
0.054 AUD +0.00099 AUD (+1.89%)
Last closed 0.054 AUD
ISIN AU000000NTI9
Sector Healthcare
Industry Medical Devices
Exchange Australian Securities Exchange
Capitalization 56 547 419 AUD
Yield for 12 month -6.90 %
1Y
3Y
5Y
10Y
15Y
NTI
21.11.2021 - 28.11.2021

Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia. Address: 145 Stirling Highway, Nedlands, WA, Australia, 6009

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+1 950 AUD

Last Year

+5 922 AUD

Current Quarter

-33 037 AUD

Last Quarter

+1 497 AUD

Current Year

-5 831 AUD

Last Year

+4 189 AUD

Current Quarter

-2 250 856 AUD

Last Quarter

-943 247 AUD

Key Figures NTI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 194 057 AUD
Operating Margin TTM 13532.16 %
PE Ratio
Return On Assets TTM -37.29 %
PEG Ratio
Return On Equity TTM -63.92 %
Wall Street Target Price
Revenue TTM 3 157 417 AUD
Book Value 0.012 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 167.5 %
Dividend Yield
Gross Profit TTM 1 187 001 AUD
Earnings per share -0.0099 AUD
Diluted Eps TTM -0.0099 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -159.54 %

Dividend Analytics NTI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NTI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 8:7
Payout Ratio
Last Split Date 01.02.2019
Dividend Date

Stock Valuation NTI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 23593.1467
Price Sales TTM 17.9094
Enterprise Value EBITDA -6.7445
Price Book MRQ 4.8693

Financials NTI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NTI

For 52 weeks

0.048 AUD 0.12 AUD
50 Day MA 0.059 AUD
Shares Short Prior Month
200 Day MA 0.078 AUD
Short Ratio
Shares Short
Short Percent